↓ Skip to main content

Thymoquinone Prevents Dopaminergic Neurodegeneration by Attenuating Oxidative Stress Via the Nrf2/ARE Pathway

Overview of attention for article published in Frontiers in Pharmacology, January 2021
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (67th percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

twitter
6 X users

Citations

dimensions_citation
26 Dimensions

Readers on

mendeley
26 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Thymoquinone Prevents Dopaminergic Neurodegeneration by Attenuating Oxidative Stress Via the Nrf2/ARE Pathway
Published in
Frontiers in Pharmacology, January 2021
DOI 10.3389/fphar.2020.615598
Pubmed ID
Authors

Jianjian Dong, Xiaoming Zhang, Shijing Wang, Chenchen Xu, Manli Gao, Songyang Liu, Xiaoxiao Li, Nan Cheng, Yongsheng Han, Xun Wang, Yongzhu Han

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 26 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 26 100%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 2 8%
Student > Ph. D. Student 2 8%
Other 1 4%
Lecturer 1 4%
Student > Bachelor 1 4%
Other 3 12%
Unknown 16 62%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 2 8%
Neuroscience 2 8%
Medicine and Dentistry 2 8%
Nursing and Health Professions 1 4%
Unspecified 1 4%
Other 2 8%
Unknown 16 62%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 September 2023.
All research outputs
#7,302,125
of 25,802,847 outputs
Outputs from Frontiers in Pharmacology
#3,260
of 20,019 outputs
Outputs of similar age
#173,609
of 534,688 outputs
Outputs of similar age from Frontiers in Pharmacology
#140
of 590 outputs
Altmetric has tracked 25,802,847 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 20,019 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 534,688 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 590 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.